1,721,160 research outputs found

    Keeping their own and integrating the other: medicinal plant use among Ormurs and Pathans in South Waziristan, Pakistan

    Full text link
    BackgroundIn multicultural societies, traditional knowledge among minorities faces several challenges. Minority groups often face difficult situations living in specific peripheral geographies and striving to retain their biocultural heritage, including medicinal plant knowledge and practices. Folk medicinal plant knowledge is a dynamic eco-cultural complex influenced by various environmental, socio-cultural, and political factors. Examining medicinal plant knowledge among minorities has been an increasingly popular topic in cross-cultural ethnobiology. It also helps understand the dynamics of local/traditional ecological knowledge (LEK/TEK) change within a given community. The current study was designed to investigate the status of medicinal plant knowledge among two linguistic groups, i.e. Ormurs and Pathans, living in a remote valley of West Pakistan.MethodsWe recruited 70 male study participants from the studied groups for semi-structured interviews to record the medicinal plant use of their communities. Data were compared among the two studied communities using the stacked charts employing the presence or absence of data with Past 4.03 and Venn diagrams. Use reports (URs) were counted for each recorded taxon.Results and DiscussionA total of seventy-four medicinal plants were quoted as used as ethnomedicines by the researched communities. Most of the reported plants were used to treat digestive and liver problems. The cross-cultural comparison revealed a considerable homogeneity of medicinal plant knowledge (the two groups commonly used more than seventy plants); however, comparing uses recorded for the widely utilised medicinal plants showed numerous idiosyncratic uses among Ormurs but very few among Pathans. Ormurs reported a higher number of cultivated, wild, and imported plant uses than did Pathans. These results indicate that, compared to Pathans, the Ormur linguistic minority retain more folk medicinal plant knowledge, which may be explained by the fact that they have incorporated different folk remedies: their "own knowledge" plus that of Pathans, with whom they have lived together for centuries. Moreover, the local plant nomenclature among Ormurs was highly affected by the plant nomenclature of Pathans.ConclusionThe current study revealed that living together for a few centuries has not implied sharing plant knowledge (as the Pathans do not seem to have learnt from the Ormurs) or, in other words, that plant knowledge exchanges have been unidirectional. The findings show that the Pashto dominant culture may have possibly put pressure on the minority groups and affected local plant-centred cultural practices, as we see in the case of local plant nomenclature hybridisation among Omuri speakers. Hence, it is imperative to employ diverse educational strategies to revitalise the decline of medicinal plant knowledge in the studied communities, especially among Ormurs, who need more attention as they face more challenges than the other group. Locally based strategies should be devised to restore the fading connection with nature, which will be advantageous for revitalising plant knowledge

    A COMPUTATIONAL MODEL OF A HUMAN VENTRICULAR CARDIOMYOCYTE: POSSIBLE ROLES IN CARDIOVASCULAR DISEASE AND ARRHYTHMIAS

    Full text link
    Studying cardiac diseases using human tissue is proven difficult and limited, even in optimized clinical conditions. Computer simulation studies have been continuously researched by mimicking electrophysiological protocols which can now be accommodated in the present time due to their high computational load. In that regard, we have developed a stochastic human ventricular cardiomyocyte model for intracellular calcium ([Ca2+]i) handling to include 9 individual L-Type calcium (LCC) and 49 ryanodine receptor (RyR) channels as components of 20,000 Ca2+–release units (CRUs). The model presented here explores the intricacies of calcium-induced calcium-release (CICR) dynamics, with a particular focus on the interplay between LCCs and a cluster of RyRs within CRUs. This framework elucidates the fundamental aspects of excitation-contraction coupling. Various ionic pumps and currents contained in the cell membrane contribute to the overall electrophysiological behavior of the cardiac action potential (AP) morphology. Moreover, cardiac contractility is regulated by fine–tuning multiple fluxes involved in [Ca2+]i concentrations and impacts signaling pathways by spontaneous calcium release from the sarcoplasmic reticulum (SR). However, Ca2+ ions also indicate the presence of abnormalities observed in the behavior of the cardiomyocyte’s AP and intracellular Ca2+ dynamics which may ultimately result to arrhythmogenic disorders. The model presented here captures the spontaneous Ca2+ release events and can be further used to explore both normal and defective mechanisms in ventricular cardiac abnormalities

    Advancements in Computational Digital Pathology for EGFR and pd-l1

    Full text link
    Annually Inova Health Care System treats more than two million individuals through their integrated network. With the increasing need for fast and accurate results for its cancer patients, the Inova Laboratories Healthcare System’s reference laboratory, has acquired a Rapid Molecular Testing System, called BioCartis Idyllatm which is a real-time PCR bases molecular testing system. This system is user friendly and will help improve the turnaround time for diagnosis and treatment of cancer patients. Most of the existing molecular testing for Next-Generation Sequencing (NGS) platforms such as whole genome sequencing, Exon sequencing and Disease diagnosis panel takes approximately fourteen days or longer to obtain results. This is due to the need for high volume batched samples, specimen procurement, transportation and complex interpretation. While there have been great expansion of knowledge on molecular changes occurring in the cancer development, clinical utility of molecular tests for the diagnosis and especially for the treatment of cancers have been limited. The FDA has approved some treatments targeted for specific molecular changes such as EGFR mutation and KRAS mutation in lung cancers and BRAF mutation in melanomas. Molecular testing aids the pathologist to check for certain changes in a gene or chromosome that may cause or affect the chance of developing a specific disease or disorder, in this case lung cancer. Another area of rapid progress is the advancement of immune targeted therapy aimed at PD-L1. Initially applied to lung cancers and some GI cancers, and has been approved by FDA- for multiple cancer types recently. To be able to apply these advanced therapeutics there is a growing need for more efficient targeted biomarker testing, including fast TAT (turnaround time), user friendliness, remarkable accuracy, specificity and sensitivity which are equivalent to the NGS test results The objective of this project is to determine the use of rapid molecular tests for tumor mutations and the application of AI-based digital scoring methods of IHC (immunohistochemistry) test for PD-L1 for Keytruda® (Pembrolizumab)
    corecore